Envoy Medical, Inc.
The research page contains a warning that has not been mapped to a supported model interpretation. The company research remains available, but the complete score is withheld until the warning is reviewed.
COCH · Price history
Price at last available close
$6.50
−$0.31 (-4.55%) 1M
2026-10-29
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Envoy Medical, Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 13, 2026. A research update is not a new financial filing.
Who they are
Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St.
How they make money
Envoy Medical is a hearing health company that focuses on the development of fully implanted hearing devices. The company generates revenue primarily through the sale of its medical devices, though it has historically generated limited revenue and remains in a stage of ongoing research, development, and clinical testing for its investigational products.
Products & services
The company develops fully implanted hearing solutions, including the Esteem active middle ear implant and the investigational Acclaim cochlear implant, which are designed to eliminate the need for external microphones or wearable hardware.
Brands & revenue mix
Fully implanted active middle ear implant commercially available in the U.S. since 2010.
Separate brand revenue is not available in this research.Source
Investigational fully implanted cochlear implant device.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer concentration
No quantified customer-concentration disclosure is available in the current saved research.
Suppliers, materials & equipment
- Contract manufacturers — The company relies on third-party contract manufacturers for the production of its medical devices and components; specific supplier names are not disclosed.Source
Competitors
Strengths
- Proprietary fully implanted sensor technology with over two decades of experience.Source
Sources
Company-specific research
Questions worth answering for COCH
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving COCH's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •How long can COCH fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •How is COCH likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •What specifically needs to improve for COCH to reach sustainable profitability?
- •What future growth or profitability would be needed to justify COCH's current valuation?
Essential Investment Snapshot
Market Cap
$50.3M
P/E Ratio
-1.0
EPS
$-0.67
52-Week High
$1.89
52-Week Low
$0.36
Beta
1.90
Analyst Target
$2.00
Shares Outstanding
77.2M
Total Debt
$810K
Dividend
No current dividend
Liquidation Value / Share
$0.04
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Neutral / mixed momentum
Normal movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for COCH
Detected from reported data — verify before acting.Severe debt stress
Negative shareholder equity • Total debt is at least one year of revenue • Interest coverage is below 2x • Free cash flow is negative
Reverse-split headline · Oct 22, 2026
Envoy Medical Announces Reverse Stock Split — This is a provider-linked headline, not an independently confirmed event. Check the article and company filings for the subject, proposed/completed status, and subsequent updates.
Newsfile CorpCommunity Sentiment
0 active · 0 total callsNo personal call yet on COCH.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Proprietary fully implanted sensor technology with over two decades of experience.
Potential downside factors
- −Debt risk (severe): Negative shareholder equity.
- −Total debt is at least one year of revenue.
- −Interest coverage is below 2x.
- −Free cash flow is negative.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
Score changes will appear once more historical records are available.
Price vs. Value
Valuation unavailableCurrent Price
$6.50
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $207K | $241K | $225K | $316K | ···· | ···· | ···· |
| Cost of Revenue | $1.0M | $874K | $742K | $789K | ···· | ···· | ···· |
| Gross Profit | -$798K | -$633K | -$517K | -$473K | ···· | ···· | ···· |
| Research & Development | $14.0M | $12.5M | $10.2M | $9.0M | ···· | ···· | ···· |
| SG&A Expenses | $8.8M | $9.2M | $8.6M | $8.9M | ···· | ···· | ···· |
| Operating Expenses | $22.8M | $21.6M | $18.7M | $17.9M | ···· | ···· | ···· |
| EBITDA | -$21.9M | -$21.9M | -$19.8M | -$29.8M | ···· | ···· | ···· |
| Operating Income | -$23.6M | -$22.3M | -$19.3M | -$18.4M | ···· | ···· | ···· |
| Interest Expense | $471K | $1.6M | $816K | $0.00 | ···· | ···· | ···· |
| Income Before Tax | -$23.4M | -$23.8M | -$20.8M | -$29.9M | ···· | ···· | ···· |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· |
| Net Income | -$23.4M | -$23.8M | -$20.8M | -$29.9M | ···· | ···· | ···· |
| Basic EPS | $-0.67 | $-1.23 | $-1.49 | $-2.54 | ···· | ···· | ···· |
| Basic Shares | 104M | 23.26M | 18.79M | 12.55M | ···· | ···· | ···· |
| Diluted Shares | 104M | 23.26M | 18.79M | 12.55M | ···· | ···· | ···· |
Earnings Summary
Revenue
$51000
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$0.07
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-97.2%
Cash Change
+272.2%
Margin Change
-4434.5 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Cash position grew
- Debt reduced
What Weakened
- Margins contracted
Potential Score Impact
Positive indicators included cash levels, debt levels. Pressure indicators included revenue growth, EPS growth, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 34.6%. EPS declined 78.1%. Cash increased 272.2%. Total debt declined 97.2%. Net income margin declined by 4434.5 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
6 historical recordsHistorical Score Chart
3 of 6 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - DevicesNews
Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
Envoy Medical Announces Reverse Stock Split
Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
Rumor Mill · COCH
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial